Dr. Mark Belkin, MD
Claim this profileUniversity of Chicago
Studies Heart Failure
3 reported clinical trials
3 drugs studied
Affiliated Hospitals
University Of Chicago
University Of Chicago Medical Center
Clinical Trials Mark Belkin, MD is currently running
More about Mark Belkin, MD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Mark Belkin, MD has experience with
- SGLT2i
- Mavacamten
- No SGLT2i
Breakdown of trials Mark Belkin, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Belkin, MD specialize in?
Mark Belkin, MD focuses on Heart Failure and other conditions. In particular, much of their work with Heart Failure has involved treating patients, or patients who are undergoing treatment.
Is Mark Belkin, MD currently recruiting for clinical trials?
Yes, Mark Belkin, MD is currently recruiting for 1 clinical trial in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Mark Belkin, MD has studied deeply?
Yes, Mark Belkin, MD has studied treatments such as SGLT2i, Mavacamten, No SGLT2i.
What is the best way to schedule an appointment with Mark Belkin, MD?
Apply for one of the trials that Mark Belkin, MD is conducting.
What is the office address of Mark Belkin, MD?
The office of Mark Belkin, MD is located at: University of Chicago, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.